Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
Tichakunda Mharazanye, Pharmacy student at RIMT University, shared on LinkedIn about a recent article he and his colleague co-authored, adding:
”A new year, new challenges, and new milestones
The start of this year came with its fair share of pressure, tight deadlines and moments of selfdoubt.
Staying consistent, focused and curious helped me push through and l am grateful to begin the year by sharing my latest review publication.
Our work explores hemophilia beyond clotting factors, focusing on albumin as an underappreciated prognostic and diagnostic marker.
The review highlights how albumin reflects disease burden, influences bleeding severity and joint outcomes, and plays a key role in the pharmacokinetics of modern hemophilia therapies opening doors for more personalized prophylaxis.
Grateful for the learning process, the resilience it builds, and the opportunity to contribute to advancing patient-centered care in hemophilia.”
Title: Hemophilia And Albumin: Quantitative Analysis For Prognostic And Diagnostic Applications
Authors: Tichakunda Xavier Mharazanye, Shaun Muponda
Read the Full Article on The International Journal of Engineering Development and Research

More winner stories featured in Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines